Traditional Chinese medicine
Evodia (wu zhu yu)Tetradium ruticarpum (syn. Evodia rutaecarpa)
A hot, bitter fruit the texts call slightly toxic; the one human gut study we found is 14 patients on Zuo Jin Wan, and the lab record includes liver injury.
- Botanical name
- Tetradium ruticarpum (syn. Evodia rutaecarpa)
- Part used
- nearly ripe fruit, processed before use
- Also called
- pinyin Wu zhu yu (吴茱萸); Evodia fruit, Euodiae fructus, Tetradii fructus
- Used in
- Traditional Chinese medicine
- Taken for
- Nausea, Reflux and heartburn, Cramping and pain, Loose stools and diarrhea
- Sold as
- dried fruit, pills in formulas, decoction, granules
What evodia (wu zhu yu) is
Evodia is the fruit of Tetradium ruticarpum, long known in the literature as Evodia rutaecarpa, a small tree of the citrus family. The Chinese name is wu zhu yu and the pharmacopoeia name is Euodiae Fructus. A review calls it a versatile medicine prescribed in Chinese herbal formulas and recognized in Japanese Kampo, clinically used to treat headache, vomiting, diarrhea, abdominal pain, dysmenorrhea and pelvic inflammation. The same review reports 165 chemical compounds isolated from it, chiefly alkaloids, terpenoids, flavonoids, phenolic acids, steroids and phenylpropanoids.
The fruit is not used raw in the same way as a kitchen spice. Chinese pharmacy processes it before use, and a chemistry paper examines how processing and combining it with other herbs reduces its toxicity. For the gut it appears chiefly as the small partner in Zuo Jin Wan, a pill of coptis and evodia in a 6 to 1 ratio, where the tradition pairs the cold, bitter coptis with the hot evodia. It is also the main herb of Wu Zhu Yu Tang, a decoction the texts use for cold in the stomach with vomiting and headache.
What the traditions use it for
Traditional Chinese medicine (about TCM)
Wu zhu yu is classed in the Chinese materia medica as pungent, bitter and hot, and slightly toxic, entering the liver, spleen, stomach and kidney channels. The tradition says it warms the middle, disperses cold, relieves pain and directs rebellious qi downward, and uses it for what the texts call cold in the stomach and liver with epigastric and abdominal pain, vomiting, acid regurgitation and diarrhea at dawn. In Zuo Jin Wan, which the tradition uses for what it calls liver fire invading the stomach with acid regurgitation, flank pain and a bitter taste, a small amount of evodia is paired with coptis to temper coptis’s cold. The texts’ own warning that it is slightly toxic matches the toxicity work reviewed below. These are the tradition’s own classifications and not findings about the body.
The constituents
The fruit’s best-known alkaloids are evodiamine and rutaecarpine, and a review of 165 isolated compounds lists alkaloids, terpenoids, flavonoids, phenolic acids, steroids and phenylpropanoids. In the laboratory the extracts and pure components show anti-inflammatory, antitumor, antibacterial, anti-obesity and cardiovascular activity. The same review states that bioactive components of the fruit can induce drug interaction and hepatic injury, and rutaecarpine is a selective inhibitor of the cytochrome P450 1A enzymes in mouse and human liver microsomes. A study ties the fruit’s liver toxicity in the laboratory to a dichloromethane extract. These are laboratory findings.
The human evidence
We found no controlled trial of evodia alone or of Zuo Jin Wan in a gut disease. The human data we could find are one pilot study. Fourteen patients with chronic nonatrophic gastritis took Zuo Jin Wan (coptis root and evodia fruit combined in a 6 to 1 ratio) at 6.0 g a day for two weeks. Endoscopy and biopsy showed less erosion and bile reflux, though not less red plaques or hemorrhage, and less active chronic inflammation. The inflammatory markers COX-2, IL-4 and IL-17 fell in the gastric mucosa and the serum. The abstract does not describe a control group, so the findings are before-and-after changes in a small group.
Animal work backs the formula’s traditional gut use. In a rat model of gastroesophageal reflux disease, Zuo Jin Wan at three doses reduced esophageal tissue damage and pro-inflammatory cytokines and strengthened the esophageal mucosal barrier, with effects through the MAPK/NF-kB pathway. Other laboratory papers study the formula in gastritis, ulcerative colitis and several cancers.
A published review of the fruit sums up the clinical use as traditional and the pharmacology as laboratory-based, and flags drug interaction and liver injury. What has not been tested: evodia alone in people, Zuo Jin Wan against placebo in any gut disease, and Wu Zhu Yu Tang in nausea or vomiting.
| Study | Dose | What it found |
|---|---|---|
| Pilot study, 14 patients with chronic nonatrophic gastritis (Zuo Jin Wan; abstract describes no control group) PMID 35899115 | Coptis and evodia 6:1, 6.0 g a day for 2 weeks | Less erosion, bile reflux and active chronic inflammation on endoscopy and biopsy; COX-2, IL-4, IL-17 lower |
| Rat model of gastroesophageal reflux disease, Zuo Jin Wan at three doses PMID 39662861 | Three animal doses | Less esophageal damage and cytokine release; esophageal mucosal barrier strengthened |
| Review: traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of Tetradium ruticarpum fruit PMID 32758577 | Not applicable | 165 compounds isolated; laboratory activities listed; bioactive components can induce drug interaction and hepatic injury |
| Liver microsome study of rutaecarpine PMID 11854157 | Laboratory concentrations | Selective inhibitor of cytochrome P450 1A enzymes in mouse and human liver microsomes |
Doses, in trials and in practice
The only human dose we found is the pilot study’s: Zuo Jin Wan at 6.0 g a day for two weeks, made of coptis root and evodia fruit in a 6 to 1 ratio. Because the ratio is 6 to 1, evodia is the smaller share of that daily amount. In the tradition the fruit is processed first, and the processing and the pairing with other herbs are studied in a paper as ways of reducing its toxicity. Wu Zhu Yu Tang and other decoctions are made with the fruit as the main herb. We found no single-herb gram dose for a gut outcome that we could tie to a primary source.
The amounts above are what trials and pharmacopoeias record, not a dose for you; your medicines and conditions change the answer, and a clinician or pharmacist who knows them is the person to ask.
What is known about safety
The fruit is the most safety-flagged herb in this group. The tradition calls it slightly toxic, a review of the fruit lists hepatic injury among its toxicology findings, and a paper finds a dichloromethane extract responsible for the fruit’s liver toxicity in the laboratory. The abstract of the 14-patient pilot study of Zuo Jin Wan does not report adverse events, and the study was small and short. We found no pregnancy or breastfeeding data in the sources. For patent-medicine pills, reviews of Asian herbal medicines have reported toxic heavy metals and undeclared prescription drugs in some Chinese preparations, mostly as anecdotal reports; this concerns the products reviewed and not every product containing evodia.
Where it meets prescription medicines
The documented interaction mechanism is enzyme inhibition. Rutaecarpine, an alkaloid of evodia, was a selective inhibitor of the cytochrome P450 1A enzymes in mouse and human liver microsomes, and a review of the fruit states that its components can cause drug interactions. CYP1A2, one of that family, is the enzyme used as the caffeine probe in a human enzyme study, so caffeine and other medicines cleared by that route are the ones pharmacologists would look at; this is a laboratory signal and no human interaction trial of the fruit is reported in the sources we read. Zuo Jin Wan also contains coptis, which carries its own interaction record.
Match it to your own case
The quiz takes about three minutes, asks what you have tried and which medicines you take, and shows the products whose trials and labels fit, with the reasons.
Take the quizHerbs that sit beside it
Common questions
What is Zuo Jin Wan?
A Chinese pill made of coptis root and evodia fruit in a 6 to 1 ratio. The tradition uses it for acid regurgitation, flank pain and a bitter taste, which it calls liver fire invading the stomach. A pilot study gave it to 14 patients with gastritis for two weeks.
Has evodia been tested in people for the gut?
We found one small pilot of the formula Zuo Jin Wan in 14 patients and no trial of evodia alone. Animal and laboratory work is more extensive.
Is it toxic?
The tradition classes it as slightly toxic, and a review of the fruit lists hepatic injury among its toxicology findings. Chinese pharmacy processes the fruit before use, and a recent paper studies how processing reduces toxicity.
Can it interact with medicines?
Rutaecarpine, an alkaloid of evodia, selectively inhibited the cytochrome P450 1A enzymes in mouse and human liver microsomes. That is a laboratory finding, and no human interaction study is reported in the sources we read.
Sources
- Li M, Wang C, "Traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the fruit of Tetradium ruticarpum: A review", J Ethnopharmacol 2020;263:113231 pubmed.ncbi.nlm.nih.gov/32758577
- Ma X et al., "Metabolomics Profiles Associated with the Treatment of Zuojin Pill on Patients with Chronic Nonatrophic Gastritis", Front Pharmacol 2022;13:898680 pubmed.ncbi.nlm.nih.gov/35899115
- Cui G et al., "Investigating the therapeutic effects and potential mechanisms of Zuojin Pill in the treatment of gastroesophageal reflux disease", J Ethnopharmacol 2025;340:119230 pubmed.ncbi.nlm.nih.gov/39662861
- Ueng YF et al., "The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes", Drug Metab Dispos 2002;30:349-53 pubmed.ncbi.nlm.nih.gov/11854157
- Wang K et al., "Investigating the Material Basis and Mechanisms of Toxicity Reduction in Processing and Compatibility of Euodiae Fructus", Phytochem Anal 2025;36:1990-2010 pubmed.ncbi.nlm.nih.gov/40625066
- Dichloromethane extract is responsible for the Evodiae Fructus induced hepatotoxicity via PI3K-AKT/MAPK/p53/NF-kB signaling pathways, J Ethnopharmacol 2026;373 pubmed.ncbi.nlm.nih.gov/42586390
- Gurley BJ et al., "In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto", Clin Pharmacol Ther 2004;76:428-40 (CYP1A2 phenotyped with caffeine) pubmed.ncbi.nlm.nih.gov/15536458
- Ernst E, "Toxic heavy metals and undeclared drugs in Asian herbal medicines", Trends Pharmacol Sci 2002;23:136-9 pubmed.ncbi.nlm.nih.gov/11879681
- Bensky D, Clavey S, Stoger E, Chinese Herbal Medicine: Materia Medica, 3rd ed., Eastland Press, 2004 (nature, flavor, channels and actions as the tradition gives them) www.eastlandpress.com/products/chinese-herbal-medicine-materia-medica-portable-3rd-ed